Doxribtimine

Doxribtimine

SCHEMBL28320997

Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]c1=O.Cc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O.O

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

P

The experimentally established mechanism targets of Doxribtimine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TK1 P04183 4/20 0.61
LMNA P02545 3/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
TK2 O00142 1/20 0.60
ALOX12 P18054 1/20 0.58
ADRA1A P35348 1/20 0.58
ALB P02768 1/20 0.57
PKM P14618 1/20 0.57
BLM P54132 1/20 0.57
PMP22 Q01453 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Doxribtimine SCHEMBL325199 0.99 TK1 (0.62) TK1LMNASMN1; SMN2TK2ALOX12
Doxribtimine SCHEMBL20268971 0.92 TK1 (0.54) TK1LMNASMN1; SMN2TK2ALOX12
Doxribtimine SCHEMBL27449763 0.91 TK1 (0.72) TK1LMNASMN1; SMN2TK2ALOX12
Doxribtimine SCHEMBL787593 0.90 SLC28A1 (0.65) TK1LMNASMN1; SMN2TK2ALOX12
Doxribtimine SCHEMBL2722555 0.90 TK1 (0.73) TK1LMNASMN1; SMN2TK2ALOX12
Doxribtimine SCHEMBL14596596 0.90 TK1 (0.73) TK1LMNASMN1; SMN2TK2ALOX12
Doxribtimine SCHEMBL10382149 0.90 TK1 (0.73) TK1LMNASMN1; SMN2TK2ALOX12
Doxribtimine SCHEMBL21078835 0.90 TK1 (0.73) TK1LMNASMN1; SMN2TK2ALOX12
Doxribtimine SCHEMBL767986 0.90 TK1 (0.73) TK1LMNASMN1; SMN2TK2ALOX12
Doxribtimine SCHEMBL12718344 0.90 TK1 (0.73) TK1LMNASMN1; SMN2TK2ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106632554-B The method that 2 ', 3 '-two -3 '-deoxythymidine of dehydrogenation are synthesized by triacetyl 5-methyl-uridin 洛阳师范学院 2019-10-08 CN disclosed